Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 43, 2013, Pages 17368-17373

  Adler, Jacob J ^a   Johnson, Derrick E ^a   Heller, Brigitte L ^a   Bringman, Lauren R ^a   Ranahan, William P ^a   Conwell, Michael D ^a   Sun, Yang ^a   Hudmon, Andy ^a   Wells, Clark D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Growth control; Itch

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; LONG ACTING THYROID STIMULATOR; LONG ACTING THYROID STIMULATOR 1; LONG ACTING THYROID STIMULATOR 2; MYC PROTEIN; PROTEIN 14 3 3; SPHINGOSINE 1 PHOSPHATE; UBIQUITIN LIGASE ATROPHIN 1 INTERACTING PROTEIN 4; UNCLASSIFIED DRUG; YAP PROTEIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CYCLE ARREST; CELL GROWTH; CELL STRAIN HEK293; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GROWTH REGULATION; IN VITRO STUDY; PRIORITY JOURNAL; STARVATION; UBIQUITINATION;

BREAST CANCER; GROWTH CONTROL; ITCH;

14-3-3 PROTEINS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MCF-7 CELLS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MUTATION; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERINE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84886409934     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308236110     Document Type: Article

References (41)

1. Zhao B, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21(21): 2747-2761.
2. Yu F-X, et al. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150(4):780-791.
3. Miller E, et al. (2012) Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol 19(8):955-962.
4. Oka T, Mazack V, Sudol M(2008) Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283(41):27534-27546.
5. Pan D (2007) Hippo signaling in organ size control. Genes Dev 21(8):886-897.
6. Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13(4):246-257.
7. Hao Y, Chun A, Cheung K, Rashidi B, Yang X (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283(9):5496-5509.
8. Avruch J, et al. (2012) Protein kinases of the Hippo pathway: Regulation and substrates. Semin Cell Dev Biol 23(7):770-784.
9. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24(1): 72-85.
10. Basu S, Totty NF, Irwin MS, Sudol M, Downward J (2003) Akt phosphorylates the Yesassociated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11(1):11-23.
11. Kanai F, et al. (2000) TAZ: A novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19(24):6778-6791.
12. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15(10):1229-1241.
13. Strano S, et al. (2001) Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276(18):15164-15173.
14. Zhao B, et al. (2012) Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26(1):54-68.
15. Dupont S, et al. (2011) Role of YAP/TAZ in mechanotransduction. Nature 474(7350): 179-183.
16. Wada K-I, Itoga K, Okano T, Yonemura S, Sasaki H (2011) Hippo pathway regulation by cell morphology and stress fibers. Development 138(18):3907-3914.
17. Zhao B, et al. (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25(1):51-63.
18. Chan SW, et al. (2011) Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286(9):7018-7026.
19. Wang W, Huang J, Chen J (2011) Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286(6):4364-4370.
20. Varelas X, et al. (2010) The Crumbs complex couples cell density sensing to Hippodependent control of the TGF-β-SMAD pathway. Dev Cell 19(6):831-844.
21. Wells CD, et al. (2006) A Rich1/Amot complex regulates the Cdc42 GTPase and apicalpolarity proteins in epithelial cells. Cell 125(3):535-548.
22. Sugihara-Mizuno Y, et al. (2007) Molecular characterization of angiomotin/JEAP family proteins: Interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12(4):473-486.
23. Aase K, et al. (2007) Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev 21(16):2055-2068.
24. Ranahan WP, et al. (2011) The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signalregulated kinases. Cancer Res 71(6):2203-2211.
25. Adler JJ, et al. (2013) Amot130 adapts atrophin-1 interacting protein 4 to inhibit Yesassociated protein signaling and cell growth. J Biol Chem 288(21):15181-15193.
26. Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31(13): 3635-3641.
27. Allen JJ, et al. (2007) A semisynthetic epitope for kinase substrates. Nat Methods 4(6): 511-516.
28. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84(6):889-897.
29. Heller B, et al. (2010) Amot recognizes a juxtanuclear endocytic recycling compartment via a novel lipid binding domain. J Biol Chem 285(16):12308-12320.
30. Ernkvist M, et al. (2006) p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J 273(9):2000-2011.
31. Gagné V, et al. (2009) Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil Cytoskeleton 66(9):754-768.
32. Lai D, Ho KC, Hao Y, Yang X (2011) Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 71(7):2728-2738.
33. Zhao B, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22(14):1962-1971.
34. Kenny PA, et al. (2007) The morphologies of breast cancer cell lines in threedimensional assays correlate with their profiles of gene expression. Mol Oncol 1(1):84-96.
35. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30(3):256-268.
36. Bossuyt W, et al. (April 8, 2013) An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene, 10.1038/onc.2013.82.
37. Fan R, Kim N-G, Gumbiner BM (2013) Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide- dependent kinase-1. Proc Natl Acad Sci USA 110(7):2569-2574.
38. Cai H, Xu Y (2013) The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal 11(1):31.
39. Salah Z, Melino G, Aqeilan RI (2011) Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res 71(5): 2010-2020.
40. Paramasivam M, Sarkeshik A, Yates JR III, Fernandes MJG, McCollum D (2011) Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 22(19):3725-3733.
41. Sansores-Garcia L, et al. (2011) Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J 30(12):2325-2335.